MSCI ACWI IMI Virology Index

The MSCI ACWI IMI Virology Index is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The index aims to represent the performance of a set of companies that are associated with research and development into, as well as the commercialization of anti-viral and vaccine products, which are used to treat a range of infectious diseases.
Index code
748382
Inception date
Nov. 30, 2016
Benchmark administrator
Div Yld (%)
2.26
P/E
39.82
P/E Fwd
27.15
P/BV
2.75
Number of constituents
43
Index Market Cap
$3.48 T
Largest constituent Market Cap
$212.67 B
Smallest constituent Market Cap
$5.69 B
Average constituent Market Cap
$80.96 B
Median constituent Market Cap
$38.77 B
Does this benchmark pursue ESG objectives?
No
Data as of Jan. 31, 2025 

ESG metrics

No data available for this index

Want to learn more about MSCI indexes?
Get in touch.